ASML's Buyback Machine Keeps Running as Wall Street Cools on the Stock

ASML's record buybacks and $50B 2026 forecast signal strength, but Wall Street's Hold rating highlights valuation concerns.

There is a curious disconnect at the heart of ASML's current market narrative. One the one hand, a Wall Street research house has just slapped a "Hold" rating on the Dutch chip-equipment giant, trimming its previous "Buy" stance. On the other, the company itself is quietly buying back its own shares at record levels, issuing a 2026 revenue forecast that tops $50 billion, and paying out dividends to Brazilian depositary receipt holders as if nothing is amiss.

The downgrade from Wall Street Zen landed on a Saturday, a timing that often signals a model-driven re-rating rather than fresh fundamental intelligence. And indeed, the firm's own math appears to have shifted: fair-value estimates for the stock were lifted from roughly €1,151 to about €1,320, a meaningful improvement that still leaves limited headroom above the current price. That is the crux of the "Hold" argument — not the business, but the valuation.

The Numbers Tell a Different Story

ASML's own guidance, delivered last Wednesday, points to 2026 revenue of between $49.3 billion and $51.6 billion, underpinned by what management describes as "extremely strong" AI-driven orders for its lithography systems. That builds on the July upgrade that lifted the 2026 annual forecast to €43–45 billion. The company has said its EUV capacity is already fully booked through 2027.

The earnings picture looks equally robust. An analyst at Erste Group Bank raised the 2026 earnings-per-share estimate to $45.23 and penciled in $62.33 for 2027. Those are upward revisions that sit awkwardly with a defensive posture — they describe a company whose profitability is compounding faster than the market had anticipated.

Buybacks at the Top

Meanwhile, the buyback program rolls on. ASML Netherlands BV reported repurchases between August 3 and August 7, including 55,295 shares on August 3 and 51,871 on August 7. The timing is notable: the stock has climbed 154 percent over twelve months, and the company's market capitalization now stands at €606.72 billion, placing it among Europe's most valuable industrial groups.

Whether management believes the shares are undervalued at these levels or the program simply runs on autopilot is a question investors regularly ask. What is clear is that the buybacks signal confidence in the long-term value proposition, even as the stock trades just below its recent peak.

The Ecosystem Backs the Story

Around ASML, the supporting cast is also signaling strength. German optics maker Zeiss, whose mirrors are indispensable for ASML's most advanced machines, says it has sufficient capacity to meet booming AI demand. That is a meaningful data point for the entire supply chain.

The competitive picture reinforces the point. Challenger Source Foundry just raised $400 million from a hedge fund merely to develop lithography equipment for advanced chips — technology ASML already has in the field and fully booked. And a recent weakness in Applied Materials, triggered by Summit Insights Group's assessment that its growth lags rivals like ASML and Lam Research, underscores where the sector's real strength resides.

The Brazilian Connection

In a lesser-noticed move, ASML has also arranged a distribution for holders of its Brazilian depositary receipts (ISIN BRASMLBDR003). The third-quarter 2026 payout amounts to 0.16 real per receipt, with entitlement as of July 24 and payment on August 11. It complements the company's regular dividend policy on its ordinary shares.

Where the Stock Stands Now

The shares closed Monday at €1,626.00, up 2.3 percent on the day, leaving them roughly 7 percent below the record high of €1,748.00. That high came after a year in which the stock appreciated 141 percent — the secondary article cites 154 percent over twelve months, reflecting slightly different measurement windows. Either way, the rally has been extraordinary, and the stock's inclusion in an analyst recommendation list about three weeks ago added further momentum, with the shares trading 13.7 percent higher since.

The downgrade from Wall Street Zen is best understood as a valuation call rather than a verdict on operations. The company's order book, its capacity utilization, and its supply chain all point in one direction. The risk, as the "Hold" rating correctly identifies, is that a great deal of good news is already priced in after a year of exceptional gains. For holders, the operative story remains the business itself — the buybacks, the guidance, the bookings — not the shifting whims of screening models.